Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Swedish Orphan Biovitrum (BIOVF) had Debt to Capital Ratio of 0.18 for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$639.11M |
|
$65.83M |
|
$147.59M |
|
$491.52M |
|
$534.58M |
|
$104.53M |
|
$-22.36M |
|
$82.18M |
|
$82.18M |
|
$65.62M |
|
$65.62M |
|
$65.62M |
|
$65.62M |
|
$104.53M |
|
$205.65M |
|
343.73M |
|
347.17M |
|
$0.19 |
|
$0.19 |
|
| Balance Sheet Financials | |
$1.27B |
|
$169.22M |
|
$5.84B |
|
$7.12B |
|
$1.27B |
|
$882.34M |
|
$1.80B |
|
$3.07B |
|
$4.04B |
|
$-1.49B |
|
$4.04B |
|
344.61M |
|
| Cash Flow Statement Financials | |
$387.40M |
|
$-53.72M |
|
$-339.58M |
|
$117.99M |
|
$109.50M |
|
$-8.49M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.00 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.18 |
0.32 |
|
76.91% |
|
16.36% |
|
16.36% |
|
-- |
|
12.86% |
|
10.30% |
|
$384.61M |
|
-- |
|
-- |
|
-- |
|
0.09 |
|
0.33 |
|
0.88 |
|
101.79 |
|
1.62% |
|
-4.40% |
|
0.92% |
|
1.33% |
|
$11.73 |
|
$1.11 |
|
$1.12 |
|